Companies › RGNT

REGENTIS BIOMATERIALS LTD (RGNT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001912966 · EDGAR filings · Updated 2026-07-20

REGENTIS BIOMATERIALS LTD (RGNT) has reported institutional ownership of 10.7%, with 3 institutional managers holding positions valued at $1.69M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-20 — Foreign issuer report (6-K) filed
• 2026-07-15 — Foreign issuer report (6-K) filed
• 2026-07-13 — EFFECT filed
• 2026-07-13 — Insider transaction reported (Form 4)
• 2026-07-13 — Prospectus supplement (424B3) filed
• 2026-07-13 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, REGENTIS BIOMATERIALS LTD has 3 institutional holders and institutional ownership of 10.7%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

Fresenius SE & Co KGaA (FSNUF) · NANOVIRICIDES INC (NNVC) · APREA THERAPEUTICS INC (APRE) · Retractable Technologies Inc (RVP) · Imunon Inc (IMNN) · PLUS THERAPEUTICS INC (PSTV)